Endologix, Inc. (ELGX) Misses Q4 EPS by 1c; Guides FY12 EPS, Revs
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Research and development: 8.24M
Today's EPS Names:
ITG, MTEX, NSYS, More
Financial Fact:
Research and development: 8.24M
Today's EPS Names:
ITG, MTEX, NSYS, More
Join SI Premium – FREE
Endologix, Inc. (NASDAQ: ELGX) reported Q4 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $23.4 million versus the consensus estimate of $23.67 million.
Endologix, Inc. sees FY2012 EPS of $-0.12-$-0.18, versus the consensus of $-0.07. Endologix, Inc. sees FY2012 revenue of $102-$107 million, versus the consensus of $106.3 million.
For earnings history and earnings-related data on Endologix, Inc. (ELGX) click here.
Endologix, Inc. sees FY2012 EPS of $-0.12-$-0.18, versus the consensus of $-0.07. Endologix, Inc. sees FY2012 revenue of $102-$107 million, versus the consensus of $106.3 million.
For earnings history and earnings-related data on Endologix, Inc. (ELGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
- HSBC Upgrades Pegatron Corp. (4938:TT) to Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
